Aus G - Search Results

1

Single-dose orally administered quinolone appears to be sufficient antibiotic prophylaxis for radical retropubic prostatectomy.

Stranne J, Aus G, Hansson C, Lodding P, Pileblad E, Hugosson J. Stranne J, et al. Among authors: aus g. Scand J Urol Nephrol. 2004;38(2):143-7. doi: 10.1080/00365590310022590. Scand J Urol Nephrol. 2004. PMID: 15204401 Clinical Trial.

2

Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study.

Aus G, Pileblad E, Hugosson J. Aus G, et al. Eur Urol. 2002 Aug;42(2):133-8. doi: 10.1016/s0302-2838(02)00261-0. Eur Urol. 2002. PMID: 12160583 Clinical Trial.

3

Radical prostatectomy--long-term oncological outcome from a community hospital.

Tol-Fakkar M, Hermansson CG, Hugosson J, Pedersen K, Aus G. Tol-Fakkar M, et al. Among authors: aus g. Scand J Urol Nephrol. 2003;37(5):376-81. doi: 10.1080/003655903100014481. Scand J Urol Nephrol. 2003. PMID: 14594684

4

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).

Aus G, Becker C, Lilja H, Khatami A, Pihl CG, Hugosson J. Aus G, et al. Scand J Urol Nephrol. 2003;37(6):466-70. doi: 10.1080/00365590310001746. Scand J Urol Nephrol. 2003. PMID: 14675918

5

Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trial.

Stranne J, Aus G, Bergdahl S, Damber JE, Hugosson J, Khatami A, Lodding P. Stranne J, et al. Among authors: aus g. J Urol. 2010 Sep;184(3):984-9. doi: 10.1016/j.juro.2010.04.067. J Urol. 2010. PMID: 20643442 Clinical Trial.

6

Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.

Zackrisson B, Aus G, Lilja H, Lodding P, Pihl CG, Hugosson J. Zackrisson B, et al. Among authors: aus g. Eur Urol. 2003 Apr;43(4):327-32. doi: 10.1016/s0302-2838(03)00044-7. Eur Urol. 2003. PMID: 12667711

7

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.

Hugosson J, Aus G, Lilja H, Lodding P, Pihl CG, Pileblad E. Hugosson J, et al. Among authors: aus g. J Urol. 2003 May;169(5):1720-3. doi: 10.1097/01.ju.0000061183.43229.2e. J Urol. 2003. PMID: 12686817

8

Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection.

Zackrisson B, Ulleryd P, Aus G, Lilja H, Sandberg T, Hugosson J. Zackrisson B, et al. Among authors: aus g. Urology. 2003 Aug;62(2):278-81. doi: 10.1016/s0090-4295(03)00372-8. Urology. 2003. PMID: 12893335

9

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.

Aus G, Becker C, Franzén S, Lilja H, Lodding P, Hugosson J. Aus G, et al. Eur Urol. 2004 Feb;45(2):160-5. doi: 10.1016/j.eururo.2003.09.008. Eur Urol. 2004. PMID: 14734000 Clinical Trial.

10

The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable.

Zackrisson B, Aus G, Bergdahl S, Lilja H, Lodding P, Pihl CG, Hugosson J. Zackrisson B, et al. Among authors: aus g. J Urol. 2004 Apr;171(4):1500-3. doi: 10.1097/01.ju.0000118052.59597.83. J Urol. 2004. PMID: 15017207 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters